4/A
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0000899243-21-042710
10% owner bought 625,000 shares at $16.00 ($10,000,000)
- 10% owner acquired 2,602,264 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
SV7 Impact Medicine Fund LP · 10% owner
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-26 | Conversion : show line 1 in the form | +998,544 | 998,544 | D | ||
| 2021-10-26 | Conversion : show line 2 in the form | +998,544 | 998,544 | I | ||
| 2021-10-26 | Conversion : show line 3 in the form | +302,588 | 1,301,132 | D | ||
| 2021-10-26 | Conversion : show line 4 in the form | +302,588 | 1,301,132 | I | ||
| 2021-10-26 | Purchase : show line 5 in the form | +312,500 | $16.00 | $5,000,000 | 1,613,632 | D |
| 2021-10-26 | Purchase : show line 6 in the form | +312,500 | $16.00 | $5,000,000 | 1,613,632 | I |
| Open-market purchases · 625,000 sh · avg $16.00 · $10,000,000 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-26 | Conversion : show line 7 in the form Series B Convertible Preferred Stock | −9,486,166 | 0 | D |
| 2021-10-26 | Conversion : show line 8 in the form Series B Convertible Preferred Stock | −9,486,166 | 0 | I |
| 2021-10-26 | Conversion : show line 9 in the form Series C Convertible Preferred Stock | −2,874,595 | 0 | D |
| 2021-10-26 | Conversion : show line 10 in the form Series C Convertible Preferred Stock | −2,874,595 | 0 | I |
Loading xslF345X03/doc4a.xml…